Pure Global

Taiwan Diabetes Registry - Trial NCT06143449

Access comprehensive clinical trial information for NCT06143449 through Pure Global AI's free database. This phase not specified trial is sponsored by The Diabetes Association of the Republic of China (Taiwan) and is currently Recruiting. The study focuses on Diabetes Mellitus. Target enrollment is 24000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06143449
Recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT06143449
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Taiwan Diabetes Registry
Taiwan Diabetes Registry (TDR)

Study Focus

Diabetes Mellitus

Observational study - registry

Observational

other

Sponsor & Location

The Diabetes Association of the Republic of China (Taiwan)

Taipei, Taiwan

Timeline & Enrollment

N/A

Oct 01, 2015

Dec 31, 2030

24000 participants

Primary Outcome

Provide data on patient characteristics,Provide data on disease management.

Summary

To Investigate the Risk Factors, Life Style and Treatments of the Microvascular
 Disease๏ผŒMacrovascular Disease and Neuropathy in Patients With Diabetes.

ICD-10 Classifications

Diabetes mellitus
Unspecified diabetes mellitus
Other specified diabetes mellitus
Unspecified diabetes mellitus without complications
Unspecified diabetes mellitus with unspecified complications

Data Source

ClinicalTrials.gov

NCT06143449

Non-Device Trial